Author:
Huang Tengda,Yu Bingxuan,Zhou Xinyi,Pan Hongyuan,Du Ao,Bai Jincheng,Li Xiaoquan,Jiang Nan,He Jinyi,Yuan Kefei,Wang Zhen
Abstract
AbstractObjectiveSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been suggested to purpose threats to health of mankind. Alcoholic hepatitis (AH) is a life-threatening acute and chronic liver failure that takes place in sufferers who drink excessively. During the epidemic, AH has an increasing incidence of severe illness and mortality. However, for these two diseases, the intrinsic relationship of molecular pathogenesis, as well as common therapeutic strategies are still poorly understood.MethodsThe transcriptome of the COVID-19 and AH has been compared to obtain the altered genes and hub genes were screened out through protein-protein interaction (PPI) network analysis. Via gene ontology (GO), pathway enrichment and transcription regulator analysis, a deeper appreciation of the interplay mechanism between hub genes were established.ResultsWith 181 common differentially expressed genes (DEGs) of AH and COVID-19 were obtained, 10 hub genes were captured. Follow-up studies located that these 10 genes typically mediated the diseases occurrence by regulating the activities of the immune system. Other results suggest that the common pathways of the two ailments are enriched in regulating the function of immune cells and the release of immune molecules.ConclusionThis study reveals the common pathogenesis of COVID-19 and AH and assist to discover necessary therapeutic targets to combat the ongoing pandemic induced via SARS-CoV-2 infection and acquire promising remedy strategies for the two diseases.
Publisher
Cold Spring Harbor Laboratory
Reference59 articles.
1. A Novel Coronavirus from Patients with Pneumonia in China, 2019
2. Weekly epidemiological update on COVID-19-14 December 2022. p. 122. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---14-december-2022
3. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
4. SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
5. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2